IN-HOUSE MANUFACTURING FACILITY
Full Control. Fresh Cells. Zero Third-Party Dependency.
At Cellular Hope Institute, we are not simply a clinic administering stem cells.
We are a licensed regenerative medicine manufacturing facility.
Everything we use is manufactured, expanded, characterized, and quality-controlled in-house through our laboratory division.
This changes everything.
The Problem With Most Stem Cell Clinics
Many clinics:
- Purchase stem cells from third-party laboratories
- Depend on external suppliers
- Receive cells shipped through couriers
- Trust documentation provided by the manufacturer
- Do not re-verify cell counts
- Do not re-test viability upon arrival
- Store frozen vials
- Compete aggressively on price
This creates several risks.
Cold Chain Risk
When stem cells are shipped:
Cryopreservation Dependency
They rely on cryopreservation
Cold Chain Logistics
They depend on uninterrupted cold chain logistics
Transportation Variables
They are exposed to transportation variables
Viability Impact
Delays or temperature fluctuations can impact viability
Once the cells arrive, many clinics do not independently re-evaluate viability or potency.
They trust the paperwork.
Frozen vs Fresh Cells
Cryopreservation affects:
Cell Membrane Stability
Mitochondrial Function
Post-Thaw Survival Rate
Paracrine Signaling Capacity
We operate differently.
We use fresh, never-frozen mesenchymal stem cells.
Our manufacturing facility is on-site.
No couriers. No transit time. No unknown storage variables.
Cells move from laboratory to treatment suite under controlled internal transfer protocols.
Full Manufacturing Control
Our sister company, Cellgenic, operates our in-house laboratory.
We manufacture:
Umbilical cord lining mesenchymal stem cells
Exosomes
NK cell platforms
MUSE cell technologies
Pharmaceutical-grade peptides
All processes occur within our controlled laboratory environment.
We do not buy bulk cells.
We do not re-label third-party vials.
We manufacture what we administer.
Xeno-Free Expansion
We do not use fetal bovine serum.
Our culture systems are:
Xeno-free
Human plasma-based
Free from animal-derived growth factors
Designed for biological compatibility
This reduces immunologic variability and improves clinical consistency.
Hypoxic Conditioning Advantage
Most laboratories expand cells in atmospheric oxygen, which can induce stress and alter cell behavior.
We culture under controlled hypoxic conditions, meticulously replicating the physiological environment of stem cells in the body.
Why this matters:
Physiological Niche
Replicates physiological stem cell niche
Cell Resilience
Enhances cell resilience
Angiogenic Signaling
Improves angiogenic signaling
Mitochondrial Efficiency
Supports mitochondrial efficiency
Survival Rate
Increases post-administration survival
Our controlled hypoxic environment ensures optimal cell health and functionality, visible even at a microscopic level.
This meticulous approach is why our therapies are positioned as premium.
We are not competing with low-cost frozen cell distributors.
We are engineering biologically optimized cells for superior clinical outcomes.
Real-Time Cell Verification
Because we manufacture in-house, we perform:
Cell count verification
Viability testing
Sterility testing
Endotoxin screening
Surface marker characterization
Batch release review
We do not rely solely on supplier documentation.
We generate our own.
Every lot is internally verified before clinical application.
Our Three COFEPRIS Licenses
Cellular Hope Institute operates under three major authorizations from COFEPRIS (Mexico's Federal Commission for the Protection against Sanitary Risk):
1. Tissue Bank License — Allows processing, storage, and distribution of human tissues.
2. Tissue Collection License — Regulates donor sourcing and biological material acquisition.
3. Clinical Application License — Authorizes the clinical application of regenerative therapies.
These licenses are not common among regenerative clinics.
They require:
- Regulatory inspection
- Compliance documentation
- Quality system validation
- Sterility standards
- Controlled processing infrastructure
We meet these standards because we are a manufacturing facility — not a reseller.
Vertical Integration Model
Our ecosystem includes:
Cellular Hope Institute
Clinical division
Cellgenic
Laboratory manufacturing division
ISSCA
International physician training & advisory integration
This structure allows:
- Direct protocol alignment
- Scientific advisory review
- Manufacturing oversight
- Continuous quality improvement
Most clinics operate independently.
We operate as a regenerative medicine ecosystem.
Why Our Model Is Premium
We do not compete on price with volume-based clinics.
Our costs reflect:
- In-house laboratory infrastructure
- Quality control systems
- Hypoxic conditioning technology
- Xeno-free culture media
- Regulatory compliance
- Internal testing protocols
- Scientific oversight
Our model prioritizes:
- Quality over volume
- Control over outsourcing
- Freshness over shipping
- Engineering over marketing
Fresh. Controlled. Documented.
Our cells are:
- Fresh
- Manufactured on-site
- Not shipped through third-party couriers
- Not frozen for distribution
- Not sourced from unknown supply chains
Every product:
- Has batch traceability
- Has internal verification
- Is documented
- Is released only after QC approval
Transparency Commitment
Patients have the right to know:
- Where their cells were manufactured
- How they were expanded
- Whether they were frozen
- What testing was performed
- Whether viability was verified
We provide that transparency.
